This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Giuliani International Limited. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Andreas Steinbrecher: Innovator in CNS Disease Treatment
Introduction
Andreas Steinbrecher is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system (CNS) diseases. His innovative work has the potential to impact many lives positively.
Latest Patents
Steinbrecher holds a patent for "SMAD7 inhibitors for the treatment of CNS diseases." This invention relates to the use of a specific inhibitor of Smad7 expression or function for the preparation of a pharmaceutical composition aimed at preventing, ameliorating, or treating diseases of the central nervous system. The patent also discloses methods for preventing and treating such diseases, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Steinbrecher has been associated with Giuliani International Limited, where he has been able to apply his expertise in developing innovative treatments. His work has garnered attention in the pharmaceutical industry, highlighting his role as a key player in medical research and development.
Collaborations
Steinbrecher has collaborated with notable colleagues, including Ingo Kleiter and Markus Horn. These partnerships have allowed for the exchange of ideas and expertise, further enhancing the quality of research and development in their field.
Conclusion
Andreas Steinbrecher is a distinguished inventor whose work in CNS disease treatment exemplifies innovation in pharmaceuticals. His contributions, particularly through his patent on SMAD7 inhibitors, reflect his dedication to improving health outcomes.